<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Mol Biosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Mol Biosci</journal-id><journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id><journal-title-group><journal-title>Frontiers in Molecular Biosciences</journal-title></journal-title-group><issn pub-type="epub">2296-889X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7785853</article-id><article-id pub-id-type="doi">10.3389/fmolb.2020.613401</article-id><article-categories><subj-group subj-group-type="heading"><subject>Molecular Biosciences</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL<sup>pro</sup></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vincent</surname><given-names>Savariar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1092680/overview"/></contrib><contrib contrib-type="author"><name><surname>Arokiyaraj</surname><given-names>Selvaraj</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1125978/overview"/></contrib><contrib contrib-type="author"><name><surname>Saravanan</surname><given-names>Muthupandian</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/823285/overview"/></contrib><contrib contrib-type="author"><name><surname>Dhanraj</surname><given-names>Manoj</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1167261/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Centre for Environmental Research and Development (CERD), Loyola College, Loyola Institute of Frontier Energy</institution>, <addr-line>Chennai</addr-line>, <country>India</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Food Science and Biotechnology, Sejong University</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff><aff id="aff3"><sup>3</sup><institution>Division of Biomedical Science, Department of Medical Microbiology and Immunology, School of Medicine, College of Health Sciences, Mekelle University</institution>, <addr-line>Mekelle</addr-line>, <country>Ethiopia</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Balakumar Chandrasekaran, Philadelphia University, Jordan</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ding Lin, Hunan University, China; Mohammad Shahid, Children's National Hospital, United States</p></fn><corresp id="c001">*Correspondence: Savariar Vincent <email>svincentloyola@gmail.com</email></corresp><corresp id="c002">Manoj Dhanraj <email>kmdmanoj@gmail.com</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences</p></fn><fn fn-type="other" id="fn002"><p>&#x02020;These authors have contributed equally to this work and share first authorship</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>12</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>7</volume><elocation-id>613401</elocation-id><history><date date-type="received"><day>02</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Vincent, Arokiyaraj, Saravanan and Dhanraj.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Vincent, Arokiyaraj, Saravanan and Dhanraj</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The COVID-19 has now been declared a global pandemic by the World Health Organization. No approved drug is currently available; therefore, an urgent need has been developed for any antiviral therapy for COVID-19. Main protease 3CL<sup>pro</sup> of this novel Coronavirus (SARS-CoV-2) play a critical role in the disease propagation, and hence represent a crucial target for the drug discovery. Herein, we have applied a bioinformatics approach for drug repurposing to identify the possible potent inhibitors of SARS-CoV-2 main proteases 3CL<sup>pro</sup> (6LU7). In search of the anti-COVID-19 compound, we selected 145 phyto-compounds from Kabasura kudineer (KK), a poly-herbal formulation recommended by AYUSH for COVID-19 which are effective against fever, cough, sore throat, shortness of breath (similar to SARS-CoV2-like symptoms). The present study aims to identify molecules from natural products which may inhibit COVID-19 by acting on the main protease (3CL<sup>pro</sup>). Obtained results by molecular docking showed that Acetoside (&#x02212;153.06), Luteolin 7 -rutinoside (&#x02212;134.6) rutin (&#x02212;133.06), Chebulagic acid (&#x02212;124.3), Syrigaresinol (&#x02212;120.03), Acanthoside (&#x02212;122.21), Violanthin (&#x02212;114.9), Andrographidine C (&#x02212;101.8), myricetin (&#x02212;99.96), Gingerenone -A (&#x02212;93.9), Tinosporinone (&#x02212;83.42), Geraniol (&#x02212;62.87), Nootkatone (&#x02212;62.4), Asarianin (&#x02212;79.94), and Gamma sitosterol (&#x02212;81.94) are main compounds from KK plants which may inhibit COVID-19 giving the better energy score compared to synthetic drugs. Based on the binding energy score, we suggest that these compounds can be tested against Coronavirus and used to develop effective antiviral drugs.</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd>molecular docking</kwd><kwd>Kabasura kudineer</kwd><kwd>iGemdock</kwd><kwd>anti-viral effects</kwd></kwd-group><counts><fig-count count="5"/><table-count count="2"/><equation-count count="0"/><ref-count count="89"/><page-count count="12"/><word-count count="7792"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>The World Health Organization has declared novel Coronavirus disease 2019 (COVID-19) to be a pandemic that went on to affect more than 219 countries with 44,002,003 confirmed cases and killed more than 1,167,988 people (WHO as of Oct 29, 2020) (Velavan and Meyer, <xref rid="B82" ref-type="bibr">2020</xref>). The updated information is available on the WHO website (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</ext-link>). It has also ignited fears of an impending economic crisis and recession in the infected countries (Buck et al., <xref rid="B8" ref-type="bibr">2020</xref>). In India, the first case was reported on January 30, 2020; as of Oct 29, 2020; 8,040,203 cases have been confirmed by COVID-19 infection along with 7,032,000 recoveries, 120,527 deaths with the fatality rate of 1.2% (Ministry of Health and Family Welfare, India). On March 25, 2020, the Government of India announced a nationwide lockdown to cut the chain of community transmission. COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) which results in respiratory illness among infected people. There are 7 Human Corona Virus (HCoV) strains identified so far and categorized into &#x003b1;-CoV (229E and NL63) and &#x003b2;-CoV (OC43, HKU1, SARS, MERS, and COVID-19 HCoVs). Among these, MERS HCoV and SARS were reported to be more virulent and have the highest mortality (Elfiky, <xref rid="B15" ref-type="bibr">2020</xref>).</p><p>The HCoV is a positive sense virus with a single-stranded 30,000 bp RNA (+ssRNA). The virus consists of two clusters of proteins, namely (a) the non-structural RNA-dependent RNA polymerase (RRP) that is significant in the replication of the virus, and 3C-Like Protease (3CL<sup>pro</sup>) enzyme that cleaves the two polyproteins (PP1A and PP1AB) translated from viral RNA in the host cell, and (b) Spike proteins that help in fusion and entry of the virus into the host, Nucleocapsid, Matrix and Envelope proteins (Elfiky et al., <xref rid="B16" ref-type="bibr">2017</xref>).</p><p>The major symptoms include fever, cough, and breathing difficulties. So far, no vaccine is available, and no drugs have been found to cure the life-threatening coronavirus infection. But the research is continuing to identify the potent drug or vaccine. Only symptomatic relief is provided to the patients. Currently, antiviral drugs, MERS-Cov antibodies, SARS-CoV, and combination therapy of hydroxychloroquine and azithromycin are recommended (Gautret et al., <xref rid="B18" ref-type="bibr">2020</xref>; Huang et al., <xref rid="B23" ref-type="bibr">2020</xref>). These compounds prevent viral entry by inhibition of Angiotensin-Converting Enzyme 2 (ACE2) cellular receptor, acidification of cell membrane, and by immunostimulant activity. However, some reports show that the drug hydroxychloroquine is not effective for those infected with the coronavirus and shows adverse effects in patients with acute renal impairment (Pelle and Callen, <xref rid="B59" ref-type="bibr">2002</xref>; Tailor et al., <xref rid="B75" ref-type="bibr">2012</xref>).</p><p>Therefore, there is an urgent need to develop an alternative method to prevent novel SARS-CoV2 infection. Siddha medicine, an Indian medical system, uses specific polyherbal formulations for the treatment of infectious diseases (Zysk, <xref rid="B89" ref-type="bibr">2009</xref>; Rajantheran et al., <xref rid="B62" ref-type="bibr">2014</xref>).</p><p>Traditional methods of drug discovery could take years, whereas <italic>in silico</italic>-docking analysis enables large-scale screening fast, reliable, and cheaper than conventional drug development (Green and Segall, <xref rid="B20" ref-type="bibr">2014</xref>). <italic>In silico</italic> analysis, we assess the binding ability of a ligand to protein at an active site as well as to compare the binding modes of different ligands to the active site-pocket (Leach, <xref rid="B38" ref-type="bibr">2001</xref>). In this study, we used 3CL<sup>pro</sup> as a possible targeting site to treat HCoV. Previously the main protease (Mpro)/chymotrypsin-like protease (3CL<sup>pro</sup>) has been isolated through crystallization by Liu and Wang (<xref rid="B41" ref-type="bibr">2020</xref>) (PDB ID: 6LU7). The mechanism of 3CL<sup>pro</sup> is deciphered computationally as the stearic interaction with glycine in the polyproteins and forms a strong hydrogen bonding to stabilize the complex. A conserved GSCGS motif has been observed to form three consecutive turns which were consequently temporarily stabilized by PNCC. This stabilizing PNCC is located on the surface opposite to the active site and hence can be the potential drug targeting site for 3CL<sup>pro</sup> inhibitors (Wang et al., <xref rid="B83" ref-type="bibr">2020</xref>).</p><p>In search of the anti-COVID-19 compound, we selected 145 phyto-compounds from Kabasura kudineer, a poly-herbal formulation prescribed in AYUSH for COVID-19 which are effective against flu, cough, sore throat, shortness of breath (similar to SARS-CoV2 like symptoms). [AYUSH Ministry of Health Corona Advisory&#x02014;D.O. No. S. 16030/18/2019&#x02014;NAM; 06th March 2020]. Therefore, the present study involves the analysis of 145 phytocompounds from Kabasura kudineer against the structure of SARS-CoV-2 3CL<sup>pro</sup> through structure-based <italic>in silico</italic> molecular docking and to identify potent anti-COVID-19 natural compounds.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and Methods</title><p><italic>In silico</italic> docking of the protein SARS-CoV-2 virus 3CL<sup>pro</sup> (PDB ID: 6LU7), iGEMDOCK module software was used.</p><sec><title>Selection of Protein</title><p>The 3CL<sup>pro</sup>/Mpro (PDB ID: 6LU7) protein structure COVID-19 (<xref ref-type="fig" rid="F1">Figure 1</xref>) containing the two chains (A&#x00026;B) was acquired from the protein data bank (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link>). The PDB format extraction was used to study the crystal structure of the protein.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>The crystal structure of COVID-19 main protease in complex with an inhibitor N3 PDB ID: 6LU7.</p></caption><graphic xlink:href="fmolb-07-613401-g0001"/></fig></sec><sec><title>Ligand Preparation</title><p>We selected 145 phyto-compounds from Kabasura kudineer complex (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). A total of 145 two-dimensional ligands were generated with ACD chem sketch. The ligands extracted in the mol format were converted to pdb format using OPEN BABEL software (<ext-link ext-link-type="uri" xlink:href="http://www.vcclab.org/lab/babel/start.html">www.vcclab.org/lab/babel/start.html</ext-link>). The docking tool iGEMDOCK v2.0 was used for the rapid virtual screening of the extracted compounds (Yang and Chen, <xref rid="B85" ref-type="bibr">2004</xref>). Based on the highest energy value, best compounds from each plant of Kabasura kudineer complex were exposed to accurate molecular docking (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>).</p></sec><sec><title>Active Site Prediction</title><p>The most significant step in molecular docking is to locate the ligand-binding sites on a protein. The protein-ligand binding sites are located using the novel energy-based method Q-Site Finder developed by Jackson, where the interaction energies of a methyl probe with a protein are analyzed (Laurie and Jackson, <xref rid="B37" ref-type="bibr">2005</xref>). Using the software, the plausible active binding sites of toxins were obtained. The binding sites which are more flexible were preferred for this analysis.</p></sec><sec><title>Protein-Ligand Docking</title><p>After the compounds are screened, a virtual screening environment is created through an integrated tool iGEMDOCK. The tool affords the interactive interfaces to prepare both the binding site of the target protein and the screening compound library. Post-screening, each compound in the library is docked into the binding site and thereby generating the protein-compound interaction profiles of electrostatic, hydrogen-bonding, and van der Waals interactions. The tool then corroborates the pharmacological interactions and clusters the screening compounds for the post-screening analysis based on the interaction data and the compound structures, ranks and visualizes the screening compounds by combining the pharmacological interactions and energy-based scoring function. With the population size 800 set with 80 generation and 10 solutions, the ligands were subjected to very slow accurate docking and the docking pose and their corresponding energy values were analyzed.</p></sec></sec><sec id="s3"><title>Results and Discussion</title><p>The present study focused on the main proteases 3CL<sup>pro</sup> PDB ID (6LU7), as potential target proteins for SARS - COVID-19. Inhibition potential and effectiveness of compounds from Kabasura kudineer (KK) against novel coronavirus 3CL<sup>pro</sup> on molecular docking studies using Igemdock were investigated. The proteolytic maturation enzyme Mpro in CoV has been identified as the potential target protein to prevent the spread of infection through the inhibition of viral polyprotein cleavage (Liu and Wang, <xref rid="B41" ref-type="bibr">2020</xref>). The discovery of the Mpro protease structure has facilitated the identification of potential drug candidates for treatment. The protein sequences of the two Coronavirus strains SARS-CoV Mpro and the 2019-nCoV Mpro are 96% identical, and the active sites in both proteins remain free from mutations. In many viruses, proteases play essential roles in viral replication; therefore, proteases are often used as potential targets during the development of antiviral therapeutics (Chang et al., <xref rid="B11" ref-type="bibr">2019</xref>). However, the disruption of protease activity in host cells can lead to various diseases. Hence, the host proteases can be generally used as potential therapeutic targets. Several compounds from medicinal plants have been reported to show antiviral properties (Thayil and Thyagarajan, <xref rid="B77" ref-type="bibr">2016</xref>; Zakaryan et al., <xref rid="B86" ref-type="bibr">2017</xref>; Jo et al., <xref rid="B29" ref-type="bibr">2020</xref>). This study was conceived with a strategy of exploring the natural compounds which may impede the SARS-CoV-2 infection by blocking the viral entry into the host cell or inhibiting the viral polyprotein processing in the cell. In this context, KK comprises 15 individual herbs namely <italic>Andrographis paniculata, Syzygium aromaticum, Zingiber officinale, Tragia involuerta, Hygrophila auriculata, Terminaila chebula, Adhatoda vasica, Coleus ambonicus, Saussurea lappa, Clerodendrum serratum, Cypreus rotundus, Tinospora cordifolia, Sida acuta, Piper longum</italic>, and <italic>Anacyclus pyrethrum</italic>. Each plant consists of several compounds and exhibits various biological activities (<xref rid="T1" ref-type="table">Table 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>List of plants included in Kabasura kudineer, a poly herbal formulation as recommend by AYUSH.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>S. No</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Medicinal plants</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Pharmacological properties</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Andrographis paniculata</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-viral, anti-cancer, anti-inflammatory, angiogenic, anti-venom, anti-diabetic, and anti-malarial properties</td><td valign="top" align="left" rowspan="1" colspan="1">Bharati et al., <xref rid="B7" ref-type="bibr">2011</xref>; Hossain et al., <xref rid="B22" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Syzygium aromaticum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-bacterial, anti-fungal, insecticidal, analgesic, anti-spasmodic, anti-carminative, and anti-oxidant properties</td><td valign="top" align="left" rowspan="1" colspan="1">Jimoh et al., <xref rid="B27" ref-type="bibr">2017</xref>; Kaur and Kaushal, <xref rid="B31" ref-type="bibr">2019</xref>; Batiha et al., <xref rid="B6" ref-type="bibr">2020</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Zinigiber officianle</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-emetic, anti-oxidant, anti-diabetic, anti-pyretic, analgesic, anti-arthritic, and anti-inflammatory activities</td><td valign="top" align="left" rowspan="1" colspan="1">Amir et al., <xref rid="B2" ref-type="bibr">2011</xref>; Rahmani, <xref rid="B61" ref-type="bibr">2014</xref>; Marrelli et al., <xref rid="B48" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tragia involucrata</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-microbial, analgesic, anti-epileptic, anti-diabetic, anthelmintic, anti-inflammatory, anti-fertility, anti-diuretic, anti-pyretic, anti-oxidant, and cytotoxic activities</td><td valign="top" align="left" rowspan="1" colspan="1">Dhara et al., <xref rid="B13" ref-type="bibr">2000</xref>; Rao et al., <xref rid="B64" ref-type="bibr">2007</xref>; Mothana et al., <xref rid="B50" ref-type="bibr">2010</xref>; Gobalakrishnan et al., <xref rid="B19" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Hygrophila auriculata</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-cancer, hypoglycemic, aphrodisiac, anti-microbial, anti-oxidant, lipid peroxidation, hepatoprotective, and hematopoietic activity</td><td valign="top" align="left" rowspan="1" colspan="1">Hussain et al., <xref rid="B24" ref-type="bibr">2010</xref>; Salve and Bhuktar, <xref rid="B68" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Terminalia chebula</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-bacterial, anti-microbial, anti-fungal, anti-viral, anti-oxidant, anti-ulcer, and anti-helmintic</td><td valign="top" align="left" rowspan="1" colspan="1">Ashwini et al., <xref rid="B4" ref-type="bibr">2011</xref>; Rathinamoorthy and Thilagavathi, <xref rid="B65" ref-type="bibr">2014</xref>; Upadhyay et al., <xref rid="B79" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Adhatoda vasica</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-asthmatic and bronchodilator activity, wound healing activity, anti-ulcer activity, cholagogue activity, anti-allergy activity, anti-tubercular activity, abortifacient and uterotonic activity, insecticidal activity, and anti-bacterial activity</td><td valign="top" align="left" rowspan="1" colspan="1">Singh et al., <xref rid="B72" ref-type="bibr">2011</xref>; Gangwar and Ghosh, <xref rid="B17" ref-type="bibr">2014</xref>; Kumar et al., <xref rid="B34" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Coelus amboinicus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Urolithiasis, fungitoxic, anti-bacterial, anti-malarial, and anti-inflammatory</td><td valign="top" align="left" rowspan="1" colspan="1">Pillai et al., <xref rid="B60" ref-type="bibr">2011</xref>; Rout et al., <xref rid="B67" ref-type="bibr">2012</xref>; Arumugam et al., <xref rid="B3" ref-type="bibr">2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Saussurea lappa</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-arthritic, anti-convulsant, anti-cancer, anti-inflammatory, anti-larvicidal, anti-ulcer, anti-viral, and hepatoprotective activities</td><td valign="top" align="left" rowspan="1" colspan="1">Liu et al., <xref rid="B44" ref-type="bibr">2012</xref>; Madhuri et al., <xref rid="B45" ref-type="bibr">2012</xref>; Singh et al., <xref rid="B73" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Clerodendrum serratum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-oxidant, anti-bacterial, anti- carcinogenic, hepatoprotective, wound healing, and anti-allergic properties</td><td valign="top" align="left" rowspan="1" colspan="1">Patel et al., <xref rid="B56" ref-type="bibr">2014</xref>; Noreen et al., <xref rid="B52" ref-type="bibr">2018</xref>; Mahajan et al., <xref rid="B46" ref-type="bibr">2019</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Cyperus rotundus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-androgenic, anti-mutagenic, anti-obesity, anti-oxidant, anti-uropathogenic, anti-diarrheal, anti-genotoxic, anti-cancerous, anti-convulsant, anti-diabetic, anti-bacterial, anti-lipidemic, antimalarial, anti-inflammatory, hepatoprotective, cardioprotective, and neuroprotective</td><td valign="top" align="left" rowspan="1" colspan="1">Peerzada et al., <xref rid="B58" ref-type="bibr">2015</xref>; Al-Snafi, <xref rid="B1" ref-type="bibr">2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tinospora cordifolia</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-cancer, anti-diabetes, anti-viral, anti-inflammatory, anti-psychiatric, and immunomodulatory action</td><td valign="top" align="left" rowspan="1" colspan="1">Rout, <xref rid="B66" ref-type="bibr">2006</xref>; Patel et al., <xref rid="B57" ref-type="bibr">2009</xref>; Upadhyay et al., <xref rid="B80" ref-type="bibr">2010</xref>; Gupta and Sharma, <xref rid="B21" ref-type="bibr">2011</xref>; Tiwari et al., <xref rid="B78" ref-type="bibr">2018</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Sida acuta</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-plasmodial, anti-ulcer, hypoglycemic, anti-bacterial, anti-fungal, anti-oxidant, anti-inflammatory, analgesic, anti-pyretic, hepatoprotective, and cytotoxic activities</td><td valign="top" align="left" rowspan="1" colspan="1">Karou et al., <xref rid="B30" ref-type="bibr">2017</xref>; Jindal et al., <xref rid="B28" ref-type="bibr">2012</xref>; Tcheghebe et al., <xref rid="B76" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Piper longum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-cancer, anti-oxidant, anti-inflammatory, anti-microbial, anti-hyperlipidemic, anti-obesity, and analgesic activities</td><td valign="top" align="left" rowspan="1" colspan="1">Zaveri et al., <xref rid="B88" ref-type="bibr">2010</xref>; Kumar et al., <xref rid="B36" ref-type="bibr">2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Anacyclus pyrethrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Anti-rheumatic, analgesic, anti-bacterial, anti-diabetic, anti-oxidant, anti-inflammatory, and anti-nociceptive activities</td><td valign="top" align="left" rowspan="1" colspan="1">Selles et al., <xref rid="B69" ref-type="bibr">2013</xref>; Usmani et al., <xref rid="B81" ref-type="bibr">2016</xref></td></tr></tbody></table><table-wrap-foot><p><italic>Ref: AYUSH Ministry of Health Corona Advisory&#x02014;D.O. No. S. 16030/18/2019&#x02014;NAM; dated: 06th March, 2020</italic>.</p></table-wrap-foot></table-wrap><p>From the documents of Dr. Lipinski, the molecules are categorized as the therapeutic compounds when they have sufficiently acceptable ADME properties (absorption, distribution, metabolism and excretion) and toxicity profiles to qualify through the Phase I clinical trial on humans. However, his postulate &#x0201c;rule of 5&#x0201d; classifies the molecules only based on the orally active drug phenomena that include molecular weight &#x02264; 500, clogP &#x02264; 5, H- bond donor &#x02264; 5, and H- bond acceptor &#x02264; 10. They do not evaluate the parameters of direct metabolism, frequency of the molecule or if it contains reactive functional groups.</p><p>In this present study, SARS-CoV-2 virus 3CL<sup>pro</sup> was docked with 145 compounds selected from KK comprising plants. Ritonavir, Lopinavir, Oseltamivir, HCQ, Ivermectin, and Azithromycin are used as standard (Caly et al., <xref rid="B9" ref-type="bibr">2020</xref>; Cao et al., <xref rid="B10" ref-type="bibr">2020</xref>; Muralidharan et al., <xref rid="B51" ref-type="bibr">2020</xref>). These ligands were screened based on their propensity to dock with the receptor molecule and to inhibit the protein activity. The extent of docking was ranked based on the iGEMDOCK scoring function to zero down the most accurate ligand. Eventually, during the virtual screening process, each compound from each plant that bound at different binding pockets of the 3CL<sup>pro</sup> has been selected. Based on the highest energy value, best compounds from each plant of Kabasura kudineer complex were exposed to accurate molecular docking. Based on screening process, the highest-ranked compounds (Acetoside, Luteolin 7 &#x02013;rutinoside, Rutin, Chebulagic acid, Acanthoside, Syrigaresinol, Violanthin, Andrographidine C, Myricetin, Gingerenone -A, Tinosporinone, Geraniol, Nootkatone, Asarianin, and Gamma sitosterol) were selected for accurate docking against SARS-CoV-2 virus 3CL<sup>pro</sup> and their corresponding energy values are listed in <xref rid="T2" ref-type="table">Table 2</xref> (Structure of target compounds are shown in <xref ref-type="supplementary-material" rid="SM2">Supplementary Figure 1</xref>). The energy values are inversely proportional to the acceptability of the molecule as a drug. Molecules that scored best by iGEMDOCK scoring functions were identified as potential leads for COVID-19 drug discovery process.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Accurate Molecular Docking studies on the target Phytocompounds from Kabasura kudineer (KK) with 3CL<sup>pro</sup> (6LU7) of the SARS-CoV2 Coronavirus using iGEMDOCK software.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>S. no</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Name of the plant</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Compound name</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Molecular formula and weight</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Energy</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>VDW</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>H bond</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Binding domain</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Aminoacid</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Clerodendrum serratum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Acetoside (S. Figure 1a)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>29</sub>H<sub>36</sub>O<sub>15</sub>
<break/> 624.6 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;153.06</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;93.6</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;59.46</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>H-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> H-M <break/> V-M <break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>ARG-131</bold>
<break/> THR-199 <break/> ASN-238 <break/> LEU-287 <break/> ASP-289 <break/> THR-199 <break/> TYR-239 <break/> LEU-286 <break/> LEU-287 <break/> ASP-289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Hygrophila auricualata</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Luteolin 7 -rutinoside <break/> (S. Figure 1b)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>27</sub>H<sub>30</sub>O<sub>15</sub>
<break/> 594.5 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;134.6</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;98.39</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;36.23</td><td valign="top" align="left" rowspan="1" colspan="1">H-S <break/> H-M <break/>
<bold>V-M<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1">ARG-131 <break/> THR-199 <break/> ASN-238 <break/>
<bold>LEU-287</bold>
<break/> ASP-289 <break/> THR-199 <break/> TYR-239 <break/> LEU-286 <break/> LEU-287 <break/> ASP-289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tragia involerta</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Rutin <break/> (S. Figure 1c)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>27</sub>H<sub>30</sub>O<sub>16</sub>
<break/> 610.5 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;133.06</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;85.08</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;47.99</td><td valign="top" align="left" rowspan="1" colspan="1">H-S <break/> H-M <break/> V-M <break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1">ARG-131 <break/> THR-199 <break/> LEU-287 <break/> THR-199 <break/> TYR-239 <break/> LEU-286 <break/> LEU-287 <break/> ASP-289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Terminalia chebula</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Chebulagic acid <break/> (S. Figure 1d)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>41</sub>H<sub>30</sub>O<sub>27</sub>
<break/> 954.7 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;124.3</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;103.2</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;21.28</td><td valign="top" align="left" rowspan="1" colspan="1">H-S <break/> H-M <break/> V-M <break/>
<bold>V-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold></td><td valign="top" align="left" rowspan="1" colspan="1">THR-199 <break/> LEU-287 <break/> ASP-289 <break/> THR-199 <break/>
<bold>TYR-239</bold>
<break/> LEU-286 <break/> LEU-287 <break/> ASP-289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Sida acuta</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Acanthoside <break/> (S. Figure 1f)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>34</sub>H<sub>46</sub>O<sub>18</sub>
<break/> 742.7 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;122.21</td><td valign="top" align="left" rowspan="1" colspan="1">79.44</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;42.5</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>H-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> H-M <break/> V-M <break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>ARG-131</bold>
<break/> THR-199 <break/> LEU-287 <break/> TYR-239 <break/> LEU-286 <break/> LEU-287 <break/> ASP-289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Sausurea lappa</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Syrigaresinol <break/> (S. Figure 1e)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>28</sub>H<sub>36</sub>O<sub>13</sub>
<break/> 580.6 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;120.03</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;79.99</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;40.04</td><td valign="top" align="left" rowspan="1" colspan="1">H-S<bold><xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1">ASN-151 <break/>
<bold>GLU-240</bold>
<break/> THR-292 <break/> GLY-110</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Adhatoda vasica</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Violanthin <break/> (S. Figure 1g)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>27</sub>H<sub>30</sub>O<sub>14</sub>
<break/> 578.5 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;114.9</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;76.13</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;38.81</td><td valign="top" align="left" rowspan="1" colspan="1">H-M <break/>
<bold>H-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-M</td><td valign="top" align="left" rowspan="1" colspan="1">PHE-219 <break/> ASN-221 <break/>
<bold>LEU-271</bold>
<break/> ARG-279 <break/> LEU-220</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Andrographis paniculata</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Andrographidine C <break/> (S. Figure 1h)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>23</sub>H<sub>24</sub>O<sub>10</sub>
<break/> 460.4 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;101.8</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;72.41</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;29.36</td><td valign="top" align="left" rowspan="1" colspan="1">H-S <break/> H-M <break/>
<bold>V-M<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1">ARG-131 <break/> THR-199 <break/> ASN-238 <break/> ASP-289 <break/> THR-199 <break/> TYR-239 <break/>
<bold>LEU-286</bold>
<break/> LEU-287 <break/> ASP-289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Syzygium aromaticum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Myricetin <break/> (S. Figure 1i)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>10</sub>O<sub>8</sub>
<break/> 318.23 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;99.96</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;63.64</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;36.32</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>H-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>ARG-188</bold>
<break/> GLU-55</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">10</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Zingiber Officianle</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Gingerenone -A <break/> (S. Figure 1j)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>21</sub>H<sub>24</sub>O<sub>5</sub>
<break/> 356.4 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;93.9</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;69.96</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;23.94</td><td valign="top" align="left" rowspan="1" colspan="1">H-S <break/> H-M <break/>
<bold>V-M<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1">ARG-131 <break/> THR-199 <break/>
<bold>LEU-287</bold>
<break/> ASP-289 <break/> THR-199 <break/> TYR-239 <break/> LEU-286 <break/> LEU-287 <break/> ASP-289</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">11</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tinospora cordifolia</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Tinosporinone <break/> (S. Figure 1k)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>19</sub>H<sub>18</sub>O<sub>6</sub>
<break/> 342.3 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;83.42</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;76.55</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;6.86</td><td valign="top" align="left" rowspan="1" colspan="1">H-S <break/> V-M <break/>
<bold>V-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold></td><td valign="top" align="left" rowspan="1" colspan="1">THR-199 <break/> ASP-289 <break/>
<bold>THR-199</bold>
<break/> TYR-239 <break/> LEU-287</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">12</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ceolus ambonicus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Geraniol <break/> (S. Figure 1l)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>18</sub>O <break/> 154.25 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;62.87</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;57.1</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;5.6</td><td valign="top" align="left" rowspan="1" colspan="1">H-M <break/>
<bold>V-M<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>THYR-26</bold>
<break/> LEU-141 <break/> ASN-142 <break/> LEU-4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">13</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Cypreus rotundus</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Nootkatone <break/> (S. Figure 1m)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>22</sub>O <break/> 218.33 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;62.4</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;52.51</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;9.85</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>H-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-S</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>THY 111</bold>
<break/> THY- 292 <break/> ASP- 295 <break/> PHE-294</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">14</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Piper longum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Asarianin <break/> (S. Figure 1n)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>20</sub>H<sub>18</sub>O<sub>6</sub>
<break/> 354.4 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;79.94</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;71.92</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;8.02</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>H-S<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
<break/> V-M</td><td valign="top" align="left" rowspan="1" colspan="1">TYR-239 <break/> LEU-286 <break/> LEU-287</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">15</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Anacyclus pyrethrum</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Gamma sitosterol <break/> (S. Figure 1o)</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>29</sub>H<sub>50</sub>O <break/> 414.7 g/mol</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;81.94</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;79.44</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.5</td><td valign="top" align="left" rowspan="1" colspan="1">H-S <break/>
<bold>V-M</bold></td><td valign="top" align="left" rowspan="1" colspan="1">ALA&#x02212;70 <break/> ASP-289 <break/> THR-199 <break/> TYR-239</td></tr></tbody></table><table-wrap-foot><fn id="TN1"><label>*</label><p><italic>The possible binding modes of selected phytochemicals at the target protein active sites</italic>.</p></fn><p><italic>H-S signifies hydrogen bond with sidechain</italic>.</p><p><italic>H-M signifies hydrogen bond with the main chain</italic>.</p><p><italic>V-M signifies Vander waals interaction with main chain</italic>.</p><p><italic>V-S signifies Vander waals interaction with side chain</italic>.</p><p><italic>S. Figure &#x02013; Supplementary Figure 1 (a&#x02013;o)</italic>.</p><p><italic>Bold values indicates the best interaction of amino acids along with hydrogen bond, side chain, main chain, and vander walls</italic>.</p></table-wrap-foot></table-wrap><p><xref rid="T2" ref-type="table">Table 2</xref> shows the energy value, binding domain and amino acids found in the active site pockets of 6LU7 against compounds from KK. The Acetoside from <italic>Clerodendrum serratum</italic> docked with the 3CL<sup>pro</sup> and the total fitness value was found to be &#x02212;153.06 kcal/mol, which comprises of &#x02212;93.6 van der Waal interactions and &#x02212;59.46 kcal/mol hydrogen bonding interactions. The inhibitor closely fits the active site cavity making various close contacts with the residues including hydrogen bonding with the main chain of arginine at position 131 with binding energy value &#x02212;9.3 kcal/mol (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Acteoside, a phenylethanoid glycoside, is an active compound in several plants and traditional herbal medicines (Kubica et al., <xref rid="B33" ref-type="bibr">2017</xref>). The study reports that the acetoside having the highest binding energy is very effective to inhibit the 3CL<sup>pro.</sup> Similarly, Song et al. (<xref rid="B74" ref-type="bibr">2016</xref>) reported that the acetoside inhibits viral infections in a dose-dependent manner. The interactions and fitness score of the compound suggest that these leads can be formulated as an anti-COVID drug.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>The binding affinities of target compounds <bold>(A)</bold> Acetoside, <bold>(B)</bold> Luteolin 7 -rutinoside <bold>(C)</bold> rutin <bold>(D)</bold> Chebulagic acid present in the Kabasura kudineer (KK) with 3CL<sup>pro</sup> (6LU7) of the SARS-CoV2 Coronavirus.</p></caption><graphic xlink:href="fmolb-07-613401-g0002"/></fig><p>Luteolin 7- rutinoside from <italic>Hygrophila auricualata</italic> docked with 3CL<sup>pro</sup> exhibits the energy value &#x02212;134.6 kcal/mol, which comprises of &#x02212;98.9 van der Waal interaction and &#x02212;36.23 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Here, the main chain Leucine at position 287 with binding energy is &#x02212;11.8 kcal/mol. It was predicted that the hydroxyl (-OH), ketone (=O), and ether (-O-) groups in luteolin compounds majorly impact the amino acid residue interactions at the active site of COVID-19 Mpro (Aziz et al., <xref rid="B5" ref-type="bibr">2018</xref>). Luteolin derivatives have been predicted to interact with the NS2/NS3 protease used <italic>in silico</italic> analysis showed that luteolin reduces DENV infection through the inhibition of human furin, which is an enzyme involved in the maturation of the virions (Ramana et al., <xref rid="B63" ref-type="bibr">2015</xref>; Dwivedi et al., <xref rid="B14" ref-type="bibr">2016</xref>). It is apparent from the study, that Luteolin 7- the 3CL protease.</p><p>Rutin from <italic>Tragia involerta</italic> docked with 3CL<sup>pro</sup> exhibits the energy value is &#x02212;133.06 kcal/mol, which comprises of &#x02212;85.08 van der Waal interaction and &#x02212;47.99 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Here, the main chain is arginine with H-S domain at the position 131 with binding energy &#x02212;11.8 kcal/mol. Jasso-Miranda et al. (<xref rid="B26" ref-type="bibr">2019</xref>) and Zandi et al. (<xref rid="B87" ref-type="bibr">2011</xref>) studied the antiviral activity of Rutin against Dengue virus type-2.</p><p>Chebulagic acid from <italic>Terminalia chebula</italic> docked with 3CL<sup>pro</sup> exhibits the energy value of &#x02212;124.3 kcal/mol, which comprises of &#x02212;103.02 van der Waal interaction and &#x02212;21.28 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F2">Figure 2D</xref>). The inhibitor closely fits the active site cavity making various close contacts with the residues including hydrogen bonding with the main chain of Thyronine at position 239 with binding energy value &#x02212;17.9 kcal/mol. Li et al. (<xref rid="B39" ref-type="bibr">2020</xref>) observed chebulagic acid as Novel Influenza Viral Neuraminidase Inhibitor. Similarly, Lin et al. (<xref rid="B40" ref-type="bibr">2013</xref>) also observed the chebulagic acid blocked herpes simplex virus type 1 (HSV-1).</p><p>Acanthoside isolated from <italic>Sida acuta</italic> possesses the energy value &#x02212;122.21 kcal/mol, which contains the &#x02212;79.44 van der Waal interaction and &#x02212;42.5 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F3">Figure 3B</xref>). Arginine 131 is the major active site to bind with receptors and the domain of H-S. <italic>Sida</italic> genus possesses various biological activities, especially anti-viral properties. No anti-viral reports have been reported from Acanthoside from <italic>Sida acuta</italic>.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>The binding affinities of target compounds <bold>(A)</bold> Syrigaresinol <bold>(B)</bold> Acanthoside <bold>(C)</bold> Violanthin <bold>(D)</bold> Andrographidine C present in the Kabasura kudineer (KK) with 3CL<sup>pro</sup> (6LU7) of the SARS-CoV2 Coronavirus.</p></caption><graphic xlink:href="fmolb-07-613401-g0003"/></fig><p>Docking value of Syrigaresinol (<xref ref-type="fig" rid="F3">Figure 3A</xref>) from <italic>Sausurea lappa</italic> exhibits &#x02212;120.03 kcal/mol, Violanthin from <italic>Adhatoda vasica</italic> exhibits &#x02212;114.9 kcal/mol on 3CL<sup>pro</sup> which comprises of &#x02212;79.99 and &#x02212;76.13 van der Waal interactions and &#x02212;40.04 and &#x02212;38.81 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F3">Figure 3C</xref>). The residues include hydrogen bonding with the main chain of Glucine at position 240 with binding energy value &#x02212;7.6 kcal/mol in Syrigaresinol and Leucine at position 271 with binding energy value &#x02212;8.2 kcal/mol in Violanthin respectively. Likewise, Ouyang et al. (<xref rid="B54" ref-type="bibr">2007</xref>) also studied the Syringaresinol lignan inhibiting the multiplication of the tobacco mosaic virus. No study has been reported on violanthin, but this plant exhibits various pharmacological activities. It is evident from the study both the compounds effectively inhibited the 3CL protease.</p><p>Andrographidine C from <italic>Andrographis paniculata</italic> docked with 3CL<sup>pro</sup> exhibits the energy value of &#x02212;101.8 kcal/mol, which comprises of &#x02212;72.41 van der Waal interactions and 29.36 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F3">Figure 3D</xref>). Here, the main chain and the amino acid region is leucine with V-M domain at the position 286 with binding energy &#x02212;8.3 kcal/mol. Wiart et al. (<xref rid="B84" ref-type="bibr">2005</xref>) reported Antiviral properties of ent-labdene diterpenes of <italic>Andrographis paniculata</italic> Nees, inhibitors of herpes simplex virus type 1. Similarly, Sharma et al. (<xref rid="B71" ref-type="bibr">2019</xref>) also studied that the Green synthesis of silver nanoparticles from <italic>Andrographis paniculata</italic> exhibits the antiviral potential against chikungunya virus.</p><p>Docking value of Myricetin from <italic>Syzygium aromaticum</italic> exhibits &#x02212;99.96 kcal/mol and <italic>Gingerenone</italic> from <italic>Zingiber officinale</italic> exhibits &#x02212;93.9 kcal/mol which comprises of &#x02212;63.64 and &#x02212;69.96 van der Waal interactions and &#x02212;36.32 and &#x02212;23.94 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). The residues include hydrogen bonding with the main chain of Arginine at position 188 with binding energy value &#x02212;5.2 kcal/mol in Myricetin and Leucine at position 287 with binding energy value &#x02212;5.4 kcal/mol in <italic>Gingerenone</italic> respectively. Park et al. (<xref rid="B55" ref-type="bibr">2013</xref>) and Ortega et al. (<xref rid="B53" ref-type="bibr">2017</xref>) opined that myricetin exhibits antiviral activity against influenza viruses and anti-HIV-1 activity. It is clear from the above study that myricetin exhibits anti-viral properties against COVID-19. Likewise, Gingerenone A, a polyphenol present in ginger, has attracted increasing attention as potential agents for preventing and treating many oxidative stress-related diseases. No anti-viral report has been published on this compound, but <italic>Zingiber officianle</italic> possessed excellent anti-viral properties (Sharma et al., <xref rid="B70" ref-type="bibr">2015</xref>; Kaushik et al., <xref rid="B32" ref-type="bibr">2020</xref>).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>The binding affinities of target compounds <bold>(A)</bold> myricetin <bold>(B)</bold> Gingerenone -A, <bold>(C)</bold> Tinosporinone, <bold>(D)</bold> Geraniol present in the Kabasura kudineer (KK) with 3CL<sup>pro</sup> (6LU7) of the SARS-CoV2 Coronavirus.</p></caption><graphic xlink:href="fmolb-07-613401-g0004"/></fig><p>Tinosporinone from <italic>Tinospora cordifolia</italic> exhibits the energy value &#x02212;83.42 kcal/mol, which contains the &#x02212;76.55 van der Waal interaction and &#x02212;6.86 kcal/mol hydrogen bonding interactions (<xref ref-type="fig" rid="F4">Figure 4C</xref>). The inhibitor closely binds with the specific active site making various close contacts with the residues including hydrogen bonding with the main chain of Thyronine at position 199 with binding energy value &#x02212;7.2 kcal/mol. Sharma et al. (<xref rid="B71" ref-type="bibr">2019</xref>) reported that the <italic>Tinospora cordifolia</italic> exhibits potential antiviral properties against chikungunya virus. Synergetic effects of these compounds possess excellent anti-viral properties against viral diseases.</p><p>Geraniol from <italic>Ceolus ambonicus</italic> (<xref ref-type="fig" rid="F4">Figure 4D</xref>) and Nootkatone (<xref ref-type="fig" rid="F5">Figure 5A</xref>) from <italic>Cypreus rotundus</italic> exhibit the energy value &#x02212;62.87 and &#x02212;62.4 kcal/mol which contain the &#x02212;57.1 and &#x02212;52.51 van der Waal interactions and &#x02212;5.6 and &#x02212;9.8 kcal/mol hydrogen bonding interactions. Lowest binding energy was observed in these two plants. Thyronine 26 and thyronine 111 are the major active sites to bind with 3CL<sup>pro</sup>. Mileva et al. (<xref rid="B49" ref-type="bibr">2015</xref>) reported the antiviral properties of Geraniol. Any specific anti-viral report on Nootkatone was not published and it is evident from the investigation that we can use Nootakatone as anti-viral agent for future purposes.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>The binding affinities of target compounds <bold>(A)</bold> Nootkatone <bold>(B)</bold> Asarianin and <bold>(C)</bold> gamma- sitosterol present in the Kabasura kudineer (KK) with 3CL<sup>pro</sup> (6LU7) of the SARS-CoV2 Coronavirus.</p></caption><graphic xlink:href="fmolb-07-613401-g0005"/></fig><p>Asarianin (<xref ref-type="fig" rid="F5">Figure 5B</xref>) isolated from <italic>Piper longum</italic> and Gamma sitosterol from <italic>Anacyclus pyrethrum</italic> (<xref ref-type="fig" rid="F5">Figure 5C</xref>) exhibits excellent binding energy against 3CL proviruses and it was found to be &#x02212;79.94 and &#x02212;81.94 kcal/mol which comprises of van der Waal interaction and hydrogen bonding interactions. The main active site and domain range of the Asarianin are Thyronine 239 and H-S. Likewise, Alanine 70 and V-M are the active site and binding domain of the 3CL<sup>pro</sup> on Gammasitosterol. Mair et al. (<xref rid="B47" ref-type="bibr">2016</xref>) reported the antiviral activity of piperamides from black pepper. It is the first report that <italic>Anacyclus pyrethrum</italic> possesses antiviral properties on 3CL<sup>pro</sup> by using <italic>in silico</italic> analysis.</p><p>The analysis reports of docking inclusive of the H-bonds that interact with 6LU7 amino acids are tabulated in <xref rid="T2" ref-type="table">Table 2</xref>. It was observed that every H-bond interacted with the amino acids in the COVID-19 Mpro active site. The presence of H-bonds formed further influences the binding energy. The active site is usually pivotal in analyzing whether the binding site of the ligands has interacted with the amino acids of the target or attached to any other site inside the target. In the present research, the molecular docking analysis affirmed that all the ligands from the natural compounds interacted with the active site of the target protease. The nature and amount of bonding with the active site of the protein decides the higher affinity of drug compounds. Based on the binding energy score, we suggest that Acetoside, Luteolin 7 -rutinoside, rutin, Chebulagic acid, Syrigaresinol, Acanthoside, Violanthin, Andrographidine C, and myricetin exhibit excellent anti-viral properties when compared to synthetic drugs.</p><p>Based on the binding energy score, we suggest that these compounds can be tested against Coronavirus and used to develop effective antiviral drugs. Recently, plant compounds such as flavonoids showed good docking affinity against SARS-CoV-2 3CLpro (Jo et al., <xref rid="B29" ref-type="bibr">2020</xref>) and there are several reports on Indian medicinal plants used to treat SARS-CoV infections. In line with this, <italic>Andrographis paniculata</italic> was reported to suppress NLR Family Pyrin Domain Containing 3, caspase-1 and IL-1 &#x003b2; activity on SARS-CoV and likely SARS-CoV-2 virus (Liu et al., <xref rid="B42" ref-type="bibr">2020a</xref>, Liu et al., <xref rid="B43" ref-type="bibr">2020b</xref>). Glycyrrhizin active compound from <italic>Glycyrrhiza glabra</italic> inhibits viral replication of the SARS-associated virus (Cinatl et al., <xref rid="B12" ref-type="bibr">2003</xref>). In addition to their ability to interfere with viral replication, andrographolide from <italic>Andrographis paniculata</italic> exhibits anticancer and immunostimulatory effects (Kumar et al., <xref rid="B35" ref-type="bibr">2004</xref>). Similarly, Jain et al. (<xref rid="B25" ref-type="bibr">2020</xref>) reported that the polyherbal formulation of Nilavembu Kudineer has a prophylactic effect and antiviral effect against chikungunya and dengue virus infection. This study hypothesizes that a group of compounds from KK may exert its antiviral properties against novel coronavirus SARS-CoV-2 by either blocking the host cell receptor or inhibiting the key viral protease required for its replication in the host cell. This study might render light on the drug discovery studies for the treatment of viral infections similar to SARS or COVID-19 in future.</p></sec><sec sec-type="conclusions" id="s4"><title>Conclusion</title><p>The possible medications using natural compounds were screened from approved bioactive compound databases using molecular docking techniques. This research was aimed at identifying the molecules from natural products that could effectively inhibit the COVID-19 by acting on the main protease (Mpro). Obtained results from molecular docking showed that Acetoside, Luteolin 7 -rutinoside, rutin, Chebulagic acid, Syrigaresinol, Acanthoside, Violanthin, Andrographidine C, myricetin, Gingerenone -A, Tinosporinone, Geraniol, Nootkatone, Asarianin, and sitosterol are main compounds from KK plants which may inhibit COVID-19 giving a better energy score compared to synthetic drugs. Our data suggest these results encourage further <italic>in vitro</italic> and <italic>in vivo</italic> investigations and also encourage traditional use of Kabasura kudineer preventively.</p></sec><sec sec-type="data-availability" id="s5"><title>Data Availability Statement</title><p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary Materials</xref>, further inquiries can be directed to the corresponding author/s.</p></sec><sec id="s6"><title>Author Contributions</title><p>SV and MD conceived and designed the study. SV, MD, SA, and MS carried out the coordination of the study. All authors participated during manuscript development, read, and approved the final version manuscript.</p></sec><sec sec-type="COI-statement" id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The authors thank Loyola college, Chennai, India and Sejong University, South Korea for their support.</p></ack><sec sec-type="supplementary-material" id="s7"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2020.613401/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2020.613401/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table_1.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="SM2"><media xlink:href="Image_1.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Snafi</surname><given-names>A. E.</given-names></name></person-group> (<year>2016</year>). <article-title>A review on <italic>Cyperus rotundus</italic> A potential medicinal plant</article-title>. <source>IOSR J. Pharm</source>. <volume>6</volume>, <fpage>32</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.9790/3013-06723248</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Mujeeb</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Usmani</surname><given-names>S.</given-names></name><name><surname>Akhtar</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Phytochemical analysis and <italic>in vitro</italic> antioxidant activity of <italic>Zingiber officinale</italic></article-title>. <source>Free Rad. Antioxidants</source>
<volume>1</volume>, <fpage>75</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.5530/ax.2011.4.12</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arumugam</surname><given-names>G.</given-names></name><name><surname>Swamy</surname><given-names>M. K.</given-names></name><name><surname>Sinniah</surname><given-names>U. R.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Plectranthus amboinicus</italic> (Lour.) Spreng: botanical, phytochemical, pharmacological and nutritional significance</article-title>. <source>Molecules</source>
<volume>21</volume>:<fpage>369</fpage>. <pub-id pub-id-type="doi">10.3390/molecules21040369</pub-id><?supplied-pmid 27043511?><pub-id pub-id-type="pmid">27043511</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashwini</surname><given-names>R.</given-names></name><name><surname>Gajalakshmi</surname><given-names>S.</given-names></name><name><surname>Mythili</surname><given-names>S.</given-names></name><name><surname>Sathiavelu</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Terminalia chebula</italic>-a pharmacological review</article-title>. <source>J. Pharm. Res</source>. <volume>4</volume>, <fpage>2884</fpage>&#x02013;<lpage>2887</lpage>.</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>N.</given-names></name><name><surname>Kim</surname><given-names>M. Y.</given-names></name><name><surname>Cho</surname><given-names>J. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Anti-inflammatory effects of luteolin: a review of <italic>in vitro, in vivo</italic>, and <italic>in silico</italic> studies</article-title>. <source>J. Ethnopharmacol</source>. <volume>225</volume>, <fpage>342</fpage>&#x02013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2018.05.019</pub-id><?supplied-pmid 29801717?><pub-id pub-id-type="pmid">29801717</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batiha</surname><given-names>G. E. S.</given-names></name><name><surname>Alkazmi</surname><given-names>L. M.</given-names></name><name><surname>Wasef</surname><given-names>L. G.</given-names></name><name><surname>Beshbishy</surname><given-names>A. M.</given-names></name><name><surname>Nadwa</surname><given-names>E. H.</given-names></name><name><surname>Rashwan</surname><given-names>E. K.</given-names></name></person-group> (<year>2020</year>). <article-title><italic>Syzygium aromaticum L</italic>. (<italic>Myrtaceae</italic>): traditional uses, bioactive chemical constituents, pharmacological and toxicological activities</article-title>. <source>Biomolecules</source>
<volume>10</volume>:<fpage>202</fpage>. <pub-id pub-id-type="doi">10.3390/biom10020202</pub-id><?supplied-pmid 32019140?><pub-id pub-id-type="pmid">32019140</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bharati</surname><given-names>B. D.</given-names></name><name><surname>Sharma</surname><given-names>P. K.</given-names></name><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>Dudhe</surname><given-names>R.</given-names></name><name><surname>Bansal</surname><given-names>V.</given-names></name></person-group> (<year>2011</year>). <article-title>Pharmacological activity of <italic>Andrographis paniculata</italic>: a brief review</article-title>. <source>Pharmacol. Online</source>
<volume>2</volume>:<fpage>10</fpage>.</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Buck</surname><given-names>T.</given-names></name><name><surname>Arnold</surname><given-names>M.</given-names></name><name><surname>Chazan</surname><given-names>G.</given-names></name><name><surname>Cookson</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>). <source>Coronavirus Declared a Pandemic as Fears of Economic Crisis Mount</source>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.ft.com/content/d72f1e54-6396-11ea-b3f3-fe4680ea68b5">https://www.ft.com/content/d72f1e54-6396-11ea-b3f3-fe4680ea68b5</ext-link> (accessed March 19, 2020).</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caly</surname><given-names>L.</given-names></name><name><surname>Druce</surname><given-names>J. D.</given-names></name><name><surname>Catton</surname><given-names>M. G.</given-names></name><name><surname>Jans</surname><given-names>D. A.</given-names></name><name><surname>Wagstaff</surname><given-names>K. M.</given-names></name></person-group> (<year>2020</year>). <article-title>The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 <italic>in vitro</italic></article-title>. <source>Antiviral Res</source>. <volume>178</volume>:<fpage>104787</fpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104787</pub-id><?supplied-pmid 32251768?><pub-id pub-id-type="pmid">32251768</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wen</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19</article-title>. <source>N. Engl. J. Med</source>. <volume>382</volume>, <fpage>1787</fpage>&#x02013;<lpage>1799</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2001282</pub-id><?supplied-pmid 32187464?><pub-id pub-id-type="pmid">32187464</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>K. O.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Lovell</surname><given-names>S.</given-names></name><name><surname>Rathnayake</surname><given-names>A. D.</given-names></name><name><surname>Groutas</surname><given-names>W. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Antiviral drug discovery: norovirus proteases and development of inhibitors</article-title>. <source>Viruses</source>
<volume>11</volume>:<fpage>197</fpage>. <pub-id pub-id-type="doi">10.3390/v11020197</pub-id><?supplied-pmid 30823509?><pub-id pub-id-type="pmid">30823509</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinatl</surname><given-names>J.</given-names></name><name><surname>Morgenstern</surname><given-names>B.</given-names></name><name><surname>Bauer</surname><given-names>G.</given-names></name><name><surname>Chandra</surname><given-names>P.</given-names></name><name><surname>Rabenau</surname><given-names>H.</given-names></name><name><surname>Doerr</surname><given-names>H. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus</article-title>. <source>Lancet</source>
<volume>361</volume>, <fpage>2045</fpage>&#x02013;<lpage>2046</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(03)13615-X</pub-id><?supplied-pmid 12814717?><pub-id pub-id-type="pmid">12814717</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhara</surname><given-names>A. K.</given-names></name><name><surname>Suba</surname><given-names>V.</given-names></name><name><surname>Sen</surname><given-names>T.</given-names></name><name><surname>Pal</surname><given-names>S.</given-names></name><name><surname>Chaudhuri</surname><given-names>A. N.</given-names></name></person-group> (<year>2000</year>). <article-title>Preliminary studies on the anti-inflammatory and analgesic activity of the methanolic fraction of the root extract of <italic>Tragia involucrata Linn</italic></article-title>. <source>J. Ethnopharmacol</source>. <volume>72</volume>, <fpage>265</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-8741(00)00166-5</pub-id><?supplied-pmid 10967479?><pub-id pub-id-type="pmid">10967479</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwivedi</surname><given-names>V. D.</given-names></name><name><surname>Tripathi</surname><given-names>I. P.</given-names></name><name><surname>Bharadwaj</surname><given-names>S.</given-names></name><name><surname>Kaushik</surname><given-names>A. C.</given-names></name><name><surname>Mishra</surname><given-names>S. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database</article-title>. <source>Virusdisease</source>
<volume>27</volume>, <fpage>220</fpage>&#x02013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1007/s13337-016-0328-6</pub-id><?supplied-pmid 28466032?><pub-id pub-id-type="pmid">28466032</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elfiky</surname><given-names>A. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Anti-HCV, nucleotide inhibitor, repurposed against COVID-19</article-title>. <source>Life Sci</source>. <volume>248</volume>:<fpage>117477</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2020.117477</pub-id><?supplied-pmid 32119961?><pub-id pub-id-type="pmid">32119961</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elfiky</surname><given-names>A. A.</given-names></name><name><surname>Mahdy</surname><given-names>S. M.</given-names></name><name><surname>Elshemey</surname><given-names>W. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses</article-title>. <source>J. Med. Virol</source>. <volume>89</volume>, <fpage>1040</fpage>&#x02013;<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.24736</pub-id><?supplied-pmid 27864902?><pub-id pub-id-type="pmid">27864902</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangwar</surname><given-names>A. K.</given-names></name><name><surname>Ghosh</surname><given-names>A. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Medicinal uses and pharmacological activity of <italic>Adhatoda vasica</italic></article-title>. <source>Int. J. Herbal Med</source>. <volume>2</volume>, <fpage>88</fpage>&#x02013;<lpage>91</lpage>.</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautret</surname><given-names>P.</given-names></name><name><surname>Lagier</surname><given-names>J. C.</given-names></name><name><surname>Parola</surname><given-names>P.</given-names></name><name><surname>Meddeb</surname><given-names>L.</given-names></name><name><surname>Mailhe</surname><given-names>M.</given-names></name><name><surname>Doudier</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial</article-title>. <source>Int. J. Anti-Micro. Agents</source>
<volume>56</volume>:<fpage>105949</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105949</pub-id><?supplied-pmid 32205204?><pub-id pub-id-type="pmid">32205204</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gobalakrishnan</surname><given-names>R.</given-names></name><name><surname>Kulandaivelu</surname><given-names>M.</given-names></name><name><surname>Bhuvaneswari</surname><given-names>R.</given-names></name><name><surname>Kandavel</surname><given-names>D.</given-names></name><name><surname>Kannan</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Screening of wild plant species for antibacterial activity and phytochemical analysis of <italic>Tragia involucrata L</italic></article-title>. <source>J. Pharmaceut. Anal</source>. <volume>3</volume>, <fpage>460</fpage>&#x02013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpha.2013.07.001</pub-id><?supplied-pmid 29403856?><pub-id pub-id-type="pmid">29403856</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>D. V.</given-names></name><name><surname>Segall</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Chemoinformatics in lead optimization</article-title>. <source>Chemoinformatics Drug Discov</source>. <volume>8</volume>, <fpage>149</fpage>&#x02013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1002/9781118742785.ch8</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>V.</given-names></name></person-group> (<year>2011</year>). <article-title>Ameliorative effects of <italic>Tinospora cordifolia</italic> root extract on histopathological and biochemical changes induced by aflatoxin-B1 in mice kidney</article-title>. <source>Toxicol. Int</source>. <volume>18</volume>, <fpage>94</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.4103/0971-6580.84259</pub-id><?supplied-pmid 21976812?><pub-id pub-id-type="pmid">21976812</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname><given-names>M. D.</given-names></name><name><surname>Urbi</surname><given-names>Z.</given-names></name><name><surname>Sule</surname><given-names>A.</given-names></name><name><surname>Rahman</surname><given-names>K. M.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>Andrographis paniculata</italic> (<italic>Burm. f</italic>.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology</article-title>. <source>Sci. World J.</source>
<volume>2014</volume>:<fpage>274905</fpage>. <pub-id pub-id-type="doi">10.1155/2014/274905</pub-id><?supplied-pmid 25950015?><pub-id pub-id-type="pmid">25950015</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source>Lancet</source>
<volume>395</volume>, <fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id><pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>M. S.</given-names></name><name><surname>Fareed</surname><given-names>S.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Hygrophila auriculata (K. Schum)</italic> Heine: ethnobotany, phytochemistry and pharmacology</article-title>. <source>Asian J. Traditional Med</source>. <volume>5</volume>, <fpage>122</fpage>&#x02013;<lpage>131</lpage>.</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>J.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Narayanan</surname><given-names>V.</given-names></name><name><surname>Ramaswamy</surname><given-names>R. S.</given-names></name><name><surname>Sathiyarajeswaran</surname><given-names>P.</given-names></name><name><surname>Devi</surname><given-names>M. S.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Antiviral activity of ethanolic extract of Nilavembu Kudineer against dengue and chikungunya virus through <italic>in vitro</italic> evaluation</article-title>. <source>J. Ayurveda Integrat. Med</source>. <volume>11</volume>, <fpage>329</fpage>&#x02013;<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaim.2018.05.006</pub-id><?supplied-pmid 30685096?><pub-id pub-id-type="pmid">30685096</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasso-Miranda</surname><given-names>C.</given-names></name><name><surname>Herrera-Camacho</surname><given-names>I.</given-names></name><name><surname>Flores-Mendoza</surname><given-names>L. K.</given-names></name><name><surname>Dominguez</surname><given-names>F.</given-names></name><name><surname>Vallejo-Ruiz</surname><given-names>V.</given-names></name><name><surname>Sanchez-Burgos</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies</article-title>. <source>Infect. Drug Resist</source>. <volume>12</volume>:<fpage>1833</fpage>. <pub-id pub-id-type="doi">10.2147/IDR.S210890</pub-id><?supplied-pmid 31303775?><pub-id pub-id-type="pmid">31303775</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimoh</surname><given-names>S. O.</given-names></name><name><surname>Arowolo</surname><given-names>L. A.</given-names></name><name><surname>Alabi</surname><given-names>K. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Phytochemical screening and antimicrobial evaluation of <italic>Syzygium aromaticum</italic> extract and essential oil</article-title>. <source>Int. J. Current Microbiol. Appl. Sci</source>. <volume>6</volume>, <fpage>4557</fpage>&#x02013;<lpage>4567</lpage>. <pub-id pub-id-type="doi">10.20546/ijcmas.2017.607.476</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jindal</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Extraction and pharmacological evaluation of flavonoids of <italic>sida acuta Burmf</italic></article-title>. <source>Int. J. Green Pharm</source>. <volume>6</volume>, <fpage>208</fpage>&#x02013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.4103/0973-8258.104933</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D. H.</given-names></name><name><surname>Kim</surname><given-names>M. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Inhibition of SARS-CoV 3CL protease by flavonoids</article-title>. <source>J. Enzyme Inhib. Med. Chem</source>. <volume>35</volume>, <fpage>145</fpage>&#x02013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1080/14756366.2019.1690480</pub-id><?supplied-pmid 31724441?><pub-id pub-id-type="pmid">31724441</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karou</surname><given-names>S. D.</given-names></name><name><surname>Nadembega</surname><given-names>W. M.</given-names></name><name><surname>Ilboudo</surname><given-names>D. P.</given-names></name><name><surname>Ouermi</surname><given-names>D.</given-names></name><name><surname>Gbeassor</surname><given-names>M.</given-names></name><name><surname>de Souza</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title><italic>Sida acuta Burm. f</italic>.: a medicinal plant with numerous potencies</article-title>. <source>Afr. J. Biotechnol</source>. <volume>6</volume>, <fpage>2953</fpage>&#x02013;<lpage>2959</lpage>. <pub-id pub-id-type="doi">10.5897/AJB2007.000-2463</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>K.</given-names></name><name><surname>Kaushal</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Phytochemistry and pharmacological aspects of <italic>Syzygium aromaticum</italic>: a review</article-title>. <source>J. Pharmacogn. Phytochem</source>. <volume>8</volume>, <fpage>398</fpage>&#x02013;<lpage>406</lpage>.</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushik</surname><given-names>S.</given-names></name><name><surname>Jangra</surname><given-names>G.</given-names></name><name><surname>Kundu</surname><given-names>V.</given-names></name><name><surname>Yadav</surname><given-names>J. P.</given-names></name></person-group> (<year>2020</year>). <article-title>Anti-viral activity of <italic>Zingiber officinale</italic> (Ginger) ingredients against the Chikungunya virus</article-title>. <source>Virusdisease</source>
<volume>31</volume>, <fpage>270</fpage>&#x02013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1007/s13337-020-00584-0</pub-id><?supplied-pmid 32420412?><pub-id pub-id-type="pmid">32420412</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubica</surname><given-names>P.</given-names></name><name><surname>Szopa</surname><given-names>A.</given-names></name><name><surname>Ekiert</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Production of verbascoside and phenolic acids in biomass of <italic>Verbena officinalis L</italic>. (vervain) cultured under different <italic>in vitro</italic> conditions</article-title>. <source>Nat. Prod. Res</source>. <volume>31</volume>, <fpage>1663</fpage>&#x02013;<lpage>1668</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2017.1286477</pub-id><?supplied-pmid 28278649?><pub-id pub-id-type="pmid">28278649</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Dandapat</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Sinha</surname><given-names>M. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Pharmacological screening of leaf extract of <italic>Adhatoda vasica</italic> for therapeutic efficacy</article-title>. <source>Glob. J. Pharmacol</source>. <volume>8</volume>, <fpage>494</fpage>&#x02013;<lpage>500</lpage>. <?supplied-pmid 23845144?><pub-id pub-id-type="pmid">23845144</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R. A.</given-names></name><name><surname>Sridevi</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>N. V.</given-names></name><name><surname>Nanduri</surname><given-names>S.</given-names></name><name><surname>Rajagopal</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Anticancer and immunostimulatory compounds from <italic>Andrographis paniculata</italic></article-title>. <source>J. Ethnopharmacol</source>. <volume>92</volume>, <fpage>291</fpage>&#x02013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2004.03.004</pub-id><?supplied-pmid 15138014?><pub-id pub-id-type="pmid">15138014</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Kamboj</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Overview for various aspects of the health benefits of Piper longum linn. fruit</article-title>. <source>J. Acupunct. Merid. Stud</source>. <volume>4</volume>, <fpage>134</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/S2005-2901(11)60020-4</pub-id><?supplied-pmid 21704957?><pub-id pub-id-type="pmid">21704957</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurie</surname><given-names>A. T. R.</given-names></name><name><surname>Jackson</surname><given-names>R. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Q-site finder: an energy-based method for the prediction of protein-ligand binding sites</article-title>. <source>Bioinformatics</source>
<volume>21</volume>, <fpage>1908</fpage>&#x02013;<lpage>1916</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bti315</pub-id><?supplied-pmid 15701681?><pub-id pub-id-type="pmid">15701681</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Leach</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <source>Molecular Modelling: Principles and Applications.</source>
<edition>2nd ed.</edition>
<publisher-loc>Prentice Hall, NJ</publisher-loc>: <publisher-name>Pearson Education Limited</publisher-name>.</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Du</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Identification of chebulinic acid and chebulagic acid as novel influenza viral neuraminidase inhibitors</article-title>. <source>Front. Microbiol</source>. <volume>11</volume>:<fpage>182</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.00182</pub-id><?supplied-pmid 32256457?><pub-id pub-id-type="pmid">32256457</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L. T.</given-names></name><name><surname>Chen</surname><given-names>T. Y.</given-names></name><name><surname>Lin</surname><given-names>S. C.</given-names></name><name><surname>Chung</surname><given-names>C. Y.</given-names></name><name><surname>Lin</surname><given-names>T. C.</given-names></name><name><surname>Wang</surname><given-names>G. H.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry</article-title>. <source>BMC Microbiol</source>. <volume>13</volume>:<fpage>187</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2180-13-187</pub-id><?supplied-pmid 23924316?><pub-id pub-id-type="pmid">23924316</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X. J.</given-names></name></person-group> (<year>2020</year>). <article-title>Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines</article-title>. <source>J. Genet. Genom.</source>
<volume>47</volume>, <fpage>119</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgg.2020.02.001</pub-id><?supplied-pmid 32173287?><pub-id pub-id-type="pmid">32173287</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. T.</given-names></name><name><surname>Chen</surname><given-names>H. W.</given-names></name><name><surname>Lii</surname><given-names>C. K.</given-names></name><name><surname>Jhuang</surname><given-names>J. H.</given-names></name><name><surname>Huang</surname><given-names>C. S.</given-names></name><etal/></person-group>. (<year>2020a</year>). <article-title>A diterpenoid, 14-deoxy-11, 12-didehydroandrographolide, in andrographis paniculata reduces steatohepatitis and liver injury in mice fed a high-fat and high-cholesterol diet</article-title>. <source>Nutrients</source>
<volume>12</volume>:<fpage>523</fpage>. <pub-id pub-id-type="doi">10.3390/nu12020523</pub-id><?supplied-pmid 32085637?><pub-id pub-id-type="pmid">32085637</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2020b</year>). <article-title>Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. <italic>J. Med</italic></article-title>. <source>Virol</source>. <volume>92</volume>, <fpage>595</fpage>&#x02013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.25726</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z. L.</given-names></name><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Chu</surname><given-names>S. S.</given-names></name><name><surname>Wang</surname><given-names>C. F.</given-names></name><name><surname>Du</surname><given-names>S. S.</given-names></name><name><surname>Deng</surname><given-names>Z. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Essential oil composition and larvicidal activity of <italic>Saussurea lappa</italic> roots against the mosquito <italic>Aedes albopictus</italic> (<italic>Diptera: Culicidae</italic>)</article-title>. <source>Parasitol. Res</source>. <volume>110</volume>, <fpage>2125</fpage>&#x02013;<lpage>2130</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-012-2923-9</pub-id><?supplied-pmid 22167373?><pub-id pub-id-type="pmid">22167373</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhuri</surname><given-names>K.</given-names></name><name><surname>Elango</surname><given-names>K.</given-names></name><name><surname>Ponnusankar</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Saussurea lappa</italic> (Kuth root): review of its traditional uses, phytochemistry and pharmacology</article-title>. <source>Orient. Pharmacy Exp. Med</source>. <volume>12</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s13596-011-0043-1</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>H.</given-names></name><name><surname>Singh Arora</surname><given-names>D.</given-names></name><name><surname>Singh</surname><given-names>H.</given-names></name><name><surname>Jain</surname><given-names>S. K.</given-names></name><name><surname>Namarta</surname><given-names>K.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Scientific validation of the antimicrobial and antiproliferative potential of <italic>Clerodendrum serratum (L.)</italic> moon, its phytoconstituents and their biosafety by acute oral toxicity study</article-title>. <source>Drug Chem. Toxicol</source>. <volume>1</volume>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1080/01480545.2019.1643875</pub-id><?supplied-pmid 31368375?><pub-id pub-id-type="pmid">31368375</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mair</surname><given-names>C. E.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Atanasov</surname><given-names>A. G.</given-names></name><name><surname>Schmidtke</surname><given-names>M.</given-names></name><name><surname>Dirsch</surname><given-names>V. M.</given-names></name><name><surname>Rollinger</surname><given-names>J. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Antiviral and anti-proliferative <italic>in vitro</italic> activities of piperamides from black pepper</article-title>. <source>Planta Med</source>. <volume>82</volume>:<fpage>P807</fpage>
<pub-id pub-id-type="doi">10.1055/s-0036-1596830</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrelli</surname><given-names>M.</given-names></name><name><surname>Menichini</surname><given-names>F.</given-names></name><name><surname>Conforti</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>A comparative study of <italic>Zingiber officinale Roscoe</italic> pulp and peel: phytochemical composition and evaluation of antitumour activity</article-title>. <source>Nat. Prod. Res</source>. <volume>29</volume>, <fpage>2045</fpage>&#x02013;<lpage>2049</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2015.1020491</pub-id><?supplied-pmid 25753103?><pub-id pub-id-type="pmid">25753103</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mileva</surname><given-names>M.</given-names></name><name><surname>Nikolova</surname><given-names>I.</given-names></name><name><surname>Nikolova</surname><given-names>N.</given-names></name><name><surname>Mukova</surname><given-names>L.</given-names></name><name><surname>Georgieva</surname><given-names>A.</given-names></name><name><surname>Dobreva</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Investigation of antioxidant and antiviral properties of geraniol</article-title>. <source>Acta Microbiol. Bulgarica</source>. <volume>31</volume>, <fpage>48</fpage>&#x02013;<lpage>53</lpage>.</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mothana</surname><given-names>R. A.</given-names></name><name><surname>Abdo</surname><given-names>S. A.</given-names></name><name><surname>Hasson</surname><given-names>S.</given-names></name><name><surname>Althawab</surname><given-names>F.</given-names></name><name><surname>Alaghbari</surname><given-names>S. A.</given-names></name><name><surname>Lindequist</surname><given-names>U.</given-names></name></person-group> (<year>2010</year>). <article-title>Antimicrobial, antioxidant and cytotoxic activities and phytochemical screening of some yemeni medicinal plants</article-title>. <source>Evid. Based Complement Alternat. Med</source>. <volume>7</volume>, <fpage>323</fpage>&#x02013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1093/ecam/nen004</pub-id><?supplied-pmid 18955315?><pub-id pub-id-type="pmid">18955315</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muralidharan</surname><given-names>N.</given-names></name><name><surname>Sakthivel</surname><given-names>R.</given-names></name><name><surname>Velmurugan</surname><given-names>D.</given-names></name><name><surname>Gromiha</surname><given-names>M. M.</given-names></name></person-group> (<year>2020</year>). <article-title>Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19</article-title>. <source>J. Biomol. Struct. Dyn</source>. <volume>1</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2020.1752802</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noreen</surname><given-names>R.</given-names></name><name><surname>Intisar</surname><given-names>A.</given-names></name><name><surname>Ghaffar</surname><given-names>A.</given-names></name><name><surname>Jabeen</surname><given-names>F.</given-names></name><name><surname>Abid</surname><given-names>M. A.</given-names></name><name><surname>Din</surname><given-names>M. I.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Constituents of volatile oil from bark of <italic>Clerodendrum serratum (L.)</italic> and its antibacterial activity</article-title>. <source>J. Essential Oil-Bear. Plants</source>
<volume>21</volume>, <fpage>198</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1080/0972060X.2018.1449669</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>J. T.</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>A. I.</given-names></name><name><surname>Serrano</surname><given-names>M. L.</given-names></name><name><surname>Baptista</surname><given-names>J.</given-names></name><name><surname>Pujol</surname><given-names>F. H.</given-names></name><name><surname>Rangel</surname><given-names>H. R.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of the glycosyl moiety of myricetin derivatives in anti-HIV-1 activity <italic>in vitro</italic></article-title>. <source>AIDS Res. Ther</source>. <volume>14</volume>:<fpage>57</fpage>. <pub-id pub-id-type="doi">10.1186/s12981-017-0183-6</pub-id><?supplied-pmid 29025433?><pub-id pub-id-type="pmid">29025433</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouyang</surname><given-names>M. A.</given-names></name><name><surname>Wein</surname><given-names>Y. S.</given-names></name><name><surname>Zhang</surname><given-names>Z. K.</given-names></name><name><surname>Kuo</surname><given-names>Y. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Inhibitory activity against tobacco mosaic virus (TMV) replication of pinoresinol and syringaresinol lignans and their glycosides from the root of <italic>Rhus javanica var. roxburghiana</italic></article-title>. <source>J. Agri. Food Chem</source>. <volume>55</volume>, <fpage>6460</fpage>&#x02013;<lpage>6465</lpage>. <pub-id pub-id-type="doi">10.1021/jf0709808</pub-id><?supplied-pmid 17616139?><pub-id pub-id-type="pmid">17616139</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J. I.</given-names></name><name><surname>Lee</surname><given-names>I.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hwang</surname><given-names>M. W.</given-names></name><name><surname>Bae</surname><given-names>J. Y.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses</article-title>. <source>Biochem. Biophys. Res. Commun</source>. <volume>440</volume>, <fpage>14</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.08.090</pub-id><?supplied-pmid 24012672?><pub-id pub-id-type="pmid">24012672</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>J. J.</given-names></name><name><surname>Acharya</surname><given-names>S. R.</given-names></name><name><surname>Acharya</surname><given-names>N. S.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>Clerodendrum serratum (L.)</italic> moon&#x02013;a review on traditional uses, phytochemistry and pharmacological activities</article-title>. <source>J. Ethnopharmacol</source>. <volume>154</volume>, <fpage>268</fpage>&#x02013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2014.03.071</pub-id><?supplied-pmid 24727551?><pub-id pub-id-type="pmid">24727551</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>S. S.</given-names></name><name><surname>Shah</surname><given-names>R. S.</given-names></name><name><surname>Goyal</surname><given-names>R. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Antihyperglycemic, antihyperlipidemic and antioxidant effects of Dihar, a polyherbal ayurvedic formulation in streptozotocin induced diabetic rats</article-title>. <source>Indian J. Exp. Biol</source>. <volume>47</volume>, <fpage>564</fpage>&#x02013;<lpage>570</lpage>. <?supplied-pmid 19761040?><pub-id pub-id-type="pmid">19761040</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peerzada</surname><given-names>A. M.</given-names></name><name><surname>Ali</surname><given-names>H. H.</given-names></name><name><surname>Naeem</surname><given-names>M.</given-names></name><name><surname>Latif</surname><given-names>M.</given-names></name><name><surname>Bukhari</surname><given-names>A. H.</given-names></name><name><surname>Tanveer</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Cyperus rotundus</italic> L.: Traditional uses, phytochemistry, and pharmacological activities</article-title>. <source>J. Ethnopharmacol</source>. <volume>174</volume>, <fpage>540</fpage>&#x02013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2015.08.012</pub-id><?supplied-pmid 26297840?><pub-id pub-id-type="pmid">26297840</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelle</surname><given-names>M. T.</given-names></name><name><surname>Callen</surname><given-names>J. P.</given-names></name></person-group> (<year>2002</year>). <article-title>Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous <italic>Lupus erythematosus</italic></article-title>. <source>Arch. Dermatol</source>. <volume>138</volume>, <fpage>1231</fpage>&#x02013;<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.1001/archderm.138.9.1231</pub-id><?supplied-pmid 12224986?><pub-id pub-id-type="pmid">12224986</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname><given-names>P. G.</given-names></name><name><surname>Suresh</surname><given-names>P.</given-names></name><name><surname>Aggarwal</surname><given-names>G.</given-names></name><name><surname>Doshi</surname><given-names>G.</given-names></name><name><surname>Bhatia</surname><given-names>V.</given-names></name></person-group> (<year>2011</year>). <article-title>Pharmacognostical standardization and toxicity profile of the methanolic leaf extract of <italic>Plectranthus amboinicus (Lour)</italic> spreng</article-title>. <source>J. Appl. Pharmaceut. Sci</source>. <volume>1</volume>, <fpage>76</fpage>&#x02013;<lpage>81</lpage>.</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmani</surname><given-names>A. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Active ingredients of ginger as potential candidates in the prevention and treatment of diseases <italic>via</italic> modulation of biological activities</article-title>. <source>Int. J. Physiol. Pathophysiol. Pharmacol</source>. <volume>6</volume>, <fpage>125</fpage>&#x02013;<lpage>136</lpage>. <?supplied-pmid 25057339?><pub-id pub-id-type="pmid">25057339</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajantheran</surname><given-names>M.</given-names></name><name><surname>Gill</surname><given-names>S. S.</given-names></name><name><surname>Muniapan</surname><given-names>B.</given-names></name><name><surname>Silllalee</surname><given-names>K.</given-names></name><name><surname>Manimaran</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>A critical analysis of siddha tradition in the context of Malaysian Hindu culture</article-title>. <source>Life Sci. J</source>. <volume>11</volume>, <fpage>27</fpage>&#x02013;<lpage>32</lpage>.</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramana</surname><given-names>M. M. V.</given-names></name><name><surname>Ranade</surname><given-names>P. B.</given-names></name><name><surname>Betkar</surname><given-names>R. R.</given-names></name><name><surname>Nimkar</surname><given-names>A. P.</given-names></name><name><surname>Mundhe</surname><given-names>B. C.</given-names></name><name><surname>Bhar</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Flavones: potential antidengue targets <italic>in silico</italic> approach</article-title>. <source>J. Chem. Pharm. Res</source>. <volume>7</volume>, <fpage>585</fpage>&#x02013;<lpage>591</lpage>.</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>N. V.</given-names></name><name><surname>Benoy</surname><given-names>K.</given-names></name><name><surname>Hemamalini</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>S. S.</given-names></name><name><surname>Satyanarayana</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Pharmacological evaluation of root extracts of <italic>tragia involucrata</italic></article-title>. <source>Int. J. Pharmaceut. Sci. Drug Res</source>. <volume>2</volume>, <fpage>236</fpage>&#x02013;<lpage>244</lpage>.</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathinamoorthy</surname><given-names>R.</given-names></name><name><surname>Thilagavathi</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Terminalia chebula-review on pharmacological and biochemical studies</article-title>. <source>Int. J. Pharm. Tech. Res</source>. <volume>6</volume>, <fpage>97</fpage>&#x02013;<lpage>116</lpage>.</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rout</surname><given-names>G. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of <italic>Tinospora cordifolia</italic> (Willd.) Miers ex Hook F. Thomas and Using RAPD Markers</article-title>. <source>Z Naturforsch C</source>
<volume>61</volume>, <fpage>118</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1515/znc-2006-1-221</pub-id><?supplied-pmid 16610228?><pub-id pub-id-type="pmid">16610228</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rout</surname><given-names>O. P.</given-names></name><name><surname>Acharya</surname><given-names>R.</given-names></name><name><surname>Mishra</surname><given-names>S. K.</given-names></name><name><surname>Sahoo</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Pathorchur (<italic>Coleus aromaticus</italic>): a review of the medicinal evidence for its phytochemistry and pharmacology properties</article-title>. <source>Int. J. Appl. Biol. Pharmaceut. Technol</source>. <volume>3</volume>, <fpage>348</fpage>&#x02013;<lpage>355</lpage>.</mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salve</surname><given-names>S. D.</given-names></name><name><surname>Bhuktar</surname><given-names>A. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Pharmacognosy and phytochemical evaluation of <italic>Hygrophila auriculata</italic> (<italic>Schumach</italic>.) heine root</article-title>. <source>J. Phytopharm</source>. <volume>6</volume>, <fpage>210</fpage>&#x02013;<lpage>216</lpage>.</mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selles</surname><given-names>C.</given-names></name><name><surname>Dib</surname><given-names>M. E. A.</given-names></name><name><surname>Djabou</surname><given-names>N.</given-names></name><name><surname>Beddou</surname><given-names>F.</given-names></name><name><surname>Muselli</surname><given-names>A.</given-names></name><name><surname>Tabti</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Antimicrobial activity and evolution of the composition of essential oil from <italic>Algerian Anacyclus pyrethrum L</italic>. through the vegetative cycle</article-title>. <source>Nat. Prod. Res</source>. <volume>27</volume>, <fpage>2231</fpage>&#x02013;<lpage>2234</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2013.811409</pub-id><?supplied-pmid 23803147?><pub-id pub-id-type="pmid">23803147</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>B. K.</given-names></name><name><surname>Klinzing</surname><given-names>D. C.</given-names></name><name><surname>Ramos</surname><given-names>J. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Modulatory activities of <italic>Zingiber officinale</italic> roscoe methanol extract on the expression and activity of MMPs and TIMPs on dengue virus infected cells</article-title>. <source>Asian Pacific J. Tropical Dis</source>. <volume>5</volume>, <fpage>S19</fpage>&#x02013;<lpage>S26</lpage>. <pub-id pub-id-type="doi">10.1016/S2222-1808(15)60849-0</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>V.</given-names></name><name><surname>Kaushik</surname><given-names>S.</given-names></name><name><surname>Pandit</surname><given-names>P.</given-names></name><name><surname>Dhull</surname><given-names>D.</given-names></name><name><surname>Yadav</surname><given-names>J.</given-names></name><name><surname>Kaushik</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus</article-title>. <source>Appl. Microbiol. Biotechnol</source>. <volume>103</volume>, <fpage>881</fpage>&#x02013;<lpage>891</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-018-9488-1</pub-id><?supplied-pmid 30413849?><pub-id pub-id-type="pmid">30413849</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>P. T. M.</given-names></name><name><surname>Singh</surname><given-names>O.</given-names></name><name><surname>Singh</surname><given-names>B. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Adhatoda vasica Nees: phytochemical and pharmacological profile</article-title>. <source>Nat. Prod. J</source>. <volume>1</volume>, <fpage>29</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.2174/2210316311101010029</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Chahal</surname><given-names>K. K.</given-names></name><name><surname>Singla</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Chemical composition and pharmacological activities of <italic>Saussurea lappa</italic>: a review</article-title>. <source>J. Pharmacogn. Phytochem</source>. <volume>6</volume>, <fpage>1298</fpage>&#x02013;<lpage>1308</lpage>.</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>X. P.</given-names></name><name><surname>Wu</surname><given-names>X. L.</given-names></name><name><surname>Wu</surname><given-names>H. Q.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>The antiviral effects of acteoside and the underlying IFN-&#x003b3;-inducing action</article-title>. <source>Food Func</source>. <volume>7</volume>, <fpage>3017</fpage>&#x02013;<lpage>3030</lpage>. <pub-id pub-id-type="doi">10.1039/C6FO00335D</pub-id><?supplied-pmid 27326537?><pub-id pub-id-type="pmid">27326537</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tailor</surname><given-names>R.</given-names></name><name><surname>Elaraoud</surname><given-names>I.</given-names></name><name><surname>Good</surname><given-names>P.</given-names></name><name><surname>Hope-Ross</surname><given-names>M.</given-names></name><name><surname>Scott</surname><given-names>R. A.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>A case of severe hydroxychloroquine-induced retinal toxicity in a patient with recent onset of renal</italic>: a review of the literature on the use of hydroxychloroquine in renal impairment</article-title>. <source>Case Rep. Ophthalmol. Med</source>. <volume>2012</volume>:<fpage>182747</fpage>. <pub-id pub-id-type="doi">10.1155/2012/182747</pub-id><?supplied-pmid 23304587?><pub-id pub-id-type="pmid">23304587</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tcheghebe</surname><given-names>O. T.</given-names></name><name><surname>Seukep</surname><given-names>A. J.</given-names></name><name><surname>Tatong</surname><given-names>F. N.</given-names></name></person-group> (<year>2017</year>). <article-title>Ethnomedicinal uses, phytochemical and pharmacological profiles, and toxicity of <italic>Sida acuta Burm</italic>. F.: a review article</article-title>. <source>Pharm. Innov</source>. <volume>6</volume>:<fpage>1</fpage>.</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thayil</surname><given-names>S. M.</given-names></name><name><surname>Thyagarajan</surname><given-names>S.P.</given-names></name></person-group> (<year>2016</year>). <article-title>Pa-9: a flavonoid extracted from plectranthus amboinicus inhibits HIV-1 protease</article-title>. <source>Int. J. Pharmacogn. Phytochem. Res</source>. <volume>8</volume>, <fpage>1020</fpage>&#x02013;<lpage>1024</lpage>.</mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>P.</given-names></name><name><surname>Nayak</surname><given-names>P.</given-names></name><name><surname>Prusty</surname><given-names>S. K.</given-names></name><name><surname>Sahu</surname><given-names>P. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Phytochemistry and pharmacology of <italic>Tinospora cordifolia</italic>: a review</article-title>. <source>Syst. Rev. Pharm</source>. <volume>9</volume>, <fpage>70</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.5530/srp.2018.1.14</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>A.</given-names></name><name><surname>Agrahari</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>D. K.</given-names></name></person-group> (<year>2014</year>). <article-title>A review on the pharmacological aspects of <italic>Terminalia chebula</italic></article-title>. <source>Int. J. Pharmacol</source>. <volume>10</volume>, <fpage>289</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.3923/ijp.2014.289.298</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upadhyay</surname><given-names>A. K.</given-names></name><name><surname>Kumar</surname><given-names>K.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Mishra</surname><given-names>H. S.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Tinospora cordifolia</italic> (Willd.) Hook. F. and Thoms (Guduchi)-validation of the Ayurvedic pharmacology through experimental and clinical studies</article-title>. <source>Int. J. Ayurveda Res</source>. <volume>1</volume>, <fpage>112</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.4103/0974-7788.64405</pub-id><?supplied-pmid 20814526?><pub-id pub-id-type="pmid">20814526</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usmani</surname><given-names>A.</given-names></name><name><surname>Khushtar</surname><given-names>M.</given-names></name><name><surname>Arif</surname><given-names>M.</given-names></name><name><surname>Siddiqui</surname><given-names>M. A.</given-names></name><name><surname>Sing</surname><given-names>S. P.</given-names></name><name><surname>Mujahid</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Pharmacognostic and phytopharmacology study of <italic>Anacyclus pyrethrum</italic>: an insight</article-title>. <source>J. Appl. Pharmaceut. Sci</source>. <volume>6</volume>, <fpage>144</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.7324/JAPS.2016.60325</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velavan</surname><given-names>T. P.</given-names></name><name><surname>Meyer</surname><given-names>C. G.</given-names></name></person-group> (<year>2020</year>). <article-title>The COVID-19 epidemic</article-title>. <source>Trop. Med. Int. Health</source>
<volume>25</volume>, <fpage>278</fpage>&#x02013;<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1111/tmi.13383</pub-id><?supplied-pmid 32052514?><pub-id pub-id-type="pmid">32052514</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Deng</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>Comprehensive insights into the catalytic mechanism of middle east respiratory syndrome 3C-like protease and severe acute respiratory syndrome 3C-like protease</article-title>. <source>ACS Catal</source>. <volume>10</volume>, <fpage>5871</fpage>&#x02013;<lpage>5890</lpage>. <pub-id pub-id-type="doi">10.1021/acscatal.0c00110</pub-id><?supplied-pmid 32391184?><pub-id pub-id-type="pmid">32391184</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiart</surname><given-names>C.</given-names></name><name><surname>Kumar</surname><given-names>K.</given-names></name><name><surname>Yusof</surname><given-names>M. Y.</given-names></name><name><surname>Hamimah</surname><given-names>H.</given-names></name><name><surname>Fauzi</surname><given-names>Z. M.</given-names></name><name><surname>Sulaiman</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Antiviral properties of ent-labdene diterpenes of <italic>Andrographis paniculata</italic> Nees, inhibitors of herpes simplex virus type 1</article-title>. <source>Phytother. Res</source>. <volume>19</volume>, <fpage>1069</fpage>&#x02013;<lpage>1070</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.1765</pub-id><?supplied-pmid 16372376?><pub-id pub-id-type="pmid">16372376</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J. M.</given-names></name><name><surname>Chen</surname><given-names>C. C.</given-names></name></person-group> (<year>2004</year>). <article-title>GEMDOCK: a generic evolutionary method for molecular docking</article-title>. <source>Proteins</source>
<volume>55</volume>, <fpage>288</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1002/prot.20035</pub-id><?supplied-pmid 15048822?><pub-id pub-id-type="pmid">15048822</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakaryan</surname><given-names>H.</given-names></name><name><surname>Arabyan</surname><given-names>E.</given-names></name><name><surname>Oo</surname><given-names>A.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Flavonoids: promising natural compounds against viral infections</article-title>. <source>Arch. Virol</source>. <volume>162</volume>, <fpage>2539</fpage>&#x02013;<lpage>2551</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-017-3417-y</pub-id><?supplied-pmid 28547385?><pub-id pub-id-type="pmid">28547385</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zandi</surname><given-names>K.</given-names></name><name><surname>Teoh</surname><given-names>B. T.</given-names></name><name><surname>Sam</surname><given-names>S. S.</given-names></name><name><surname>Wong</surname><given-names>P. F.</given-names></name><name><surname>Mustafa</surname><given-names>M. R.</given-names></name><name><surname>AbuBakar</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>In vitro</italic> antiviral activity of fisetin, rutin and naringenin against dengue virus type-2</article-title>. <source>J. Med. Plants Res</source>. <volume>5</volume>, <fpage>5534</fpage>&#x02013;<lpage>5539</lpage>. <pub-id pub-id-type="doi">10.1186/1743-422X-8-560</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaveri</surname><given-names>M.</given-names></name><name><surname>Khandhar</surname><given-names>A.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Chemistry and pharmacology of <italic>Piper longum L</italic></article-title>. <source>Int. J. Pharmaceut. Sci. Rev. Res</source>. <volume>5</volume>, <fpage>67</fpage>&#x02013;<lpage>76</lpage>.</mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zysk</surname><given-names>K. G.</given-names></name></person-group> (<year>2009</year>). <article-title>Some reflections on siddha medicine in Tamil Nadu</article-title>. <source>Indian J. History Sci</source>. <volume>44</volume>, <fpage>199</fpage>&#x02013;<lpage>208</lpage>.</mixed-citation></ref></ref-list></back></article>